Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1994 1
2002 1
2004 1
2005 1
2006 2
2008 11
2009 7
2010 6
2011 7
2012 14
2013 7
2014 2
2015 10
2016 10
2017 16
2018 14
2019 14
2020 14
2021 20
2022 15
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Borchmann P, Plütschow A, Kobe C, Greil R, Meissner J, Topp MS, Ostermann H, Dierlamm J, Mohm J, Thiemer J, Sökler M, Kerkhoff A, Ahlborn M, Halbsguth TV, Martin S, Keller U, Balabanov S, Pabst T, Vogelhuber M, Hüttmann A, Wilhelm M, Zijlstra JM, Moccia A, Kuhnert G, Bröckelmann PJ, von Tresckow B, Fuchs M, Klimm B, Rosenwald A, Eich H, Baues C, Marnitz S, Hallek M, Diehl V, Dietlein M, Engert A. Borchmann P, et al. Among authors: kobe c. Lancet Oncol. 2021 Feb;22(2):223-234. doi: 10.1016/S1470-2045(20)30601-X. Lancet Oncol. 2021. PMID: 33539742 Clinical Trial.
Influences on PET Quantification and Interpretation.
Rogasch JMM, Hofheinz F, van Heek L, Voltin CA, Boellaard R, Kobe C. Rogasch JMM, et al. Among authors: kobe c. Diagnostics (Basel). 2022 Feb 10;12(2):451. doi: 10.3390/diagnostics12020451. Diagnostics (Basel). 2022. PMID: 35204542 Free PMC article. Review.
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
Bröckelmann PJ, Goergen H, Keller U, Meissner J, Ordemann R, Halbsguth TV, Sasse S, Sökler M, Kerkhoff A, Mathas S, Hüttmann A, Bormann M, Zimmermann A, Mettler J, Fuchs M, von Tresckow B, Baues C, Rosenwald A, Klapper W, Kobe C, Borchmann P, Engert A. Bröckelmann PJ, et al. Among authors: kobe c. JAMA Oncol. 2020 Jun 1;6(6):872-880. doi: 10.1001/jamaoncol.2020.0750. JAMA Oncol. 2020. PMID: 32352505 Free PMC article. Clinical Trial.
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Reinke S, Bröckelmann PJ, Iaccarino I, Garcia-Marquez M, Borchmann S, Jochims F, Kotrova M, Pal K, Brüggemann M, Hartmann E, Sasse S, Kobe C, Mathas S, Soekler M, Keller U, Bormann M, Zimmermann A, Richter J, Fuchs M, von Tresckow B, Borchmann P, Schlößer H, von Bergwelt-Baildon M, Rosenwald A, Engert A, Klapper W. Reinke S, et al. Among authors: kobe c. Blood. 2020 Dec 17;136(25):2851-2863. doi: 10.1182/blood.2020008553. Blood. 2020. PMID: 33113552 Free article. Clinical Trial.
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, Topp MS, Schäfer E, Hertenstein B, Soekler M, Vogelhuber M, Zijlstra JM, Keller UB, Krause SW, Wilhelm M, Maschmeyer G, Thiemer J, Dührsen U, Meissner J, Viardot A, Eich H, Baues C, Diehl V, Rosenwald A, von Tresckow B, Dietlein M, Borchmann P, Engert A. Fuchs M, et al. Among authors: kobe c. J Clin Oncol. 2019 Nov 1;37(31):2835-2845. doi: 10.1200/JCO.19.00964. Epub 2019 Sep 10. J Clin Oncol. 2019. PMID: 31498753 Clinical Trial.
Reply to Paulo Schiavom Duarte.
Rogasch JMM, Kobe C. Rogasch JMM, et al. Among authors: kobe c. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3024-3025. doi: 10.1007/s00259-021-05469-y. Epub 2021 Jun 22. Eur J Nucl Med Mol Imaging. 2021. PMID: 34159408 Free PMC article. No abstract available.
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies.
Pilkington P, Lopci E, Adam JA, Kobe C, Goffin K, Herrmann K. Pilkington P, et al. Among authors: kobe c. Semin Nucl Med. 2021 Nov;51(6):554-571. doi: 10.1053/j.semnuclmed.2021.06.014. Epub 2021 Jul 13. Semin Nucl Med. 2021. PMID: 34272037 Review.
Moving the goalposts while scoring-the dilemma posed by new PET technologies.
Rogasch JMM, Boellaard R, Pike L, Borchmann P, Johnson P, Wolf J, Barrington SF, Kobe C. Rogasch JMM, et al. Among authors: kobe c. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2696-2710. doi: 10.1007/s00259-021-05403-2. Epub 2021 May 14. Eur J Nucl Med Mol Imaging. 2021. PMID: 33990846 Free PMC article. No abstract available.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann P, Goergen H, Kobe C, Lohri A, Greil R, Eichenauer DA, Zijlstra JM, Markova J, Meissner J, Feuring-Buske M, Hüttmann A, Dierlamm J, Soekler M, Beck HJ, Willenbacher W, Ludwig WD, Pabst T, Topp MS, Hitz F, Bentz M, Keller UB, Kühnhardt D, Ostermann H, Schmitz N, Hertenstein B, Aulitzky W, Maschmeyer G, Vieler T, Eich H, Baues C, Stein H, Fuchs M, Kuhnert G, Diehl V, Dietlein M, Engert A. Borchmann P, et al. Among authors: kobe c. Lancet. 2017 Dec 23;390(10114):2790-2802. doi: 10.1016/S0140-6736(17)32134-7. Epub 2017 Oct 20. Lancet. 2017. PMID: 29061295 Clinical Trial.
Arterial Hypertension in a 10-Year-Old Girl.
Meeser A, Beck BB, Dübbers M, Habbig S, Kobe C, Koerber F, Dötsch J, Nüsken KD, Weber LT, Landgraf P, DeCarolis B, Liebau MC. Meeser A, et al. Among authors: kobe c. Am J Kidney Dis. 2021 Mar;77(3):A11-A13. doi: 10.1053/j.ajkd.2020.08.019. Am J Kidney Dis. 2021. PMID: 33618821 No abstract available.
154 results